InnerworldM to Mergers and Acquisitions (M&A)English · 5 days agoIpsen, a global biopharmaceutical company, agreed to acquire Kartos Therapeutics, a privately held, clinical-stage biopharmaceutical company, for $1.75bnapp.mergerlinks.comexternal-linkmessage-square0linkfedilinkarrow-up12arrow-down10
arrow-up12arrow-down1external-linkIpsen, a global biopharmaceutical company, agreed to acquire Kartos Therapeutics, a privately held, clinical-stage biopharmaceutical company, for $1.75bnapp.mergerlinks.comInnerworldM to Mergers and Acquisitions (M&A)English · 5 days agomessage-square0linkfedilink